Peptide questions · Pramlintide
How long does pramlintide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Pramlintide’s onset is first meal (fullness, after-meal glucose), its peak effect comes at 16–52 weeks (weight, HbA1c), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: FDA Symlin label (DailyMed, effective December 2019); Drugs@FDA and the NDC Directory (read November 2026); Aronne 2007; Smith 2008; Kruse 2021. Approved as an add-on to mealtime insulin in diabetes; weight loss is off-label.
Pramlintide week by week
The library places four of its research notes on pramlintide on the days they cover, from day 1 to day 365: 3 on randomized trials and 1 on clinical data.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–14 (weeks 1–2) | The 15 mcg start (type 1) | Randomized trial |
| Days 1–30 (weeks 1–5) | 60 mcg, a start and a top dose | Clinical data |
| Days 4–365 (weeks 1–53) | 120 mcg, the type 2 dose | Randomized trial |
| Days 14–365 (weeks 2–53) | What it did for weight without insulin | Randomized trial |

Model. Individual results vary.
The pramlintide timeline’s milestones
The library’s timeline for pramlintide marks 5 points from week 1 to week 52, backed by clinical trial data overall.
- Week 1: Commonly reported: feeling full sooner at meals, with nausea that is highest at the start (label)
- Week 2: The label steps the dose after at least 3 days without significant nausea
- Week 4: Commonly reported: smaller meals without trying, and nausea fading for most people
- Week 16: In a 16-week obesity trial without insulin, weight fell 3.6 kg more than on placebo
- Week 52: In a 12-month obesity trial, weight stayed off in most dose groups while it came back on placebo
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why pramlintide takes that long
Pramlintide’s half-life is about 48 minutes, so one dose is about 96.9% cleared after 4 hours.
Each dose of pramlintide clears within 4 hours, so its level doesn’t build up from one day to the next: the weeks on the timeline come from repeated doses, not from the compound piling up in the blood.
The notes on pramlintide follow the trials’ dose steps, 15mcg, 60mcg and 120mcg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Pramlintide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, pramlintide among them; none of the others shares its onset of first meal (fullness, after-meal glucose).
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does pramlintide take to work?
Pramlintide’s onset is first meal (fullness, after-meal glucose), its peak effect comes at 16–52 weeks (weight, HbA1c), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does pramlintide reach its peak effect?
By the library’s timeline, pramlintide’s peak effect comes at 16–52 weeks (weight, HbA1c), backed by clinical trial data.
How long is pramlintide usually run?
The library’s timeline gives pramlintide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use with mealtime insulin; its placebo-controlled trials ran 26 to 52 weeks.
What does the library say about the first days on pramlintide?
Its first note on pramlintide, for days 1–14 (weeks 1–2), is “The 15 mcg start (type 1)”, resting on randomized trials.